CCEGF logo

Carclo plc (CCEGF) Hisse Analizi

Yalnızca bilgilendirme amaçlıdır. Finansal tavsiye değildir. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

CCEGF, $ (piyasa değeri 0) fiyatla Consumer Cyclical işi olan Carclo plc'i temsil ediyor. Büyüme potansiyeli, finansal sağlık ve momentum konusunda 46/100 (ihtiyatlı) olarak derecelendirilmiştir.

Son analiz: 16 Mar 2026
46/100 AI Puanı

Carclo plc (CCEGF) Tüketici İşletmesi Genel Bakışı

CEOFranciscus Lodewijk Paulus Doorenbosch
Çalışanlar1059
MerkezMitcham, GB
Halka Arz Yılı2012

Carclo plc, established in 1924, manufactures fine tolerance injection molded plastic components across medical, aerospace, and electronics sectors. With a global presence spanning the UK, North America, and Asia, Carclo leverages its technical plastics and aerospace divisions to serve diverse industrial needs, maintaining a modest profit margin within the consumer cyclical industry.

Veri Kaynağı | Finansal Veriler Kantitatif Analiz NASDAQ Analiz: 16 Mar 2026

Yatırım Tezi

Carclo plc presents a mixed investment thesis. The company's specialization in fine tolerance injection molded plastic parts for critical industries like medical and aerospace provides a degree of resilience. The Aerospace division, in particular, offers potential for stable, long-term contracts. However, the company's relatively small market capitalization ($0.05B) and modest profit margin (1.6%) suggest vulnerability to economic downturns and competitive pressures. A P/E ratio of 19.09 indicates that the stock is trading at a premium compared to its earnings. Key value drivers include the ability to secure and maintain contracts in the aerospace sector and the successful development of new applications for its technical plastics. Investors should closely monitor the company's ability to improve profitability and manage its cost structure. The absence of a dividend may deter some investors seeking regular income.

FMP finansallarına ve nicel analizine dayanmaktadır

Temel Önemli Noktalar

  • Market capitalization of $0.05B reflects its small-cap status within the consumer cyclical sector.
  • P/E ratio of 19.09 suggests the stock is trading at a premium relative to its earnings.
  • Profit margin of 1.6% indicates relatively low profitability, requiring close monitoring of cost management.
  • Gross margin of 56.8% demonstrates strong pricing power in its niche markets.
  • Beta of 0.70 suggests lower volatility compared to the overall market.

Rakipler & Benzerleri

Güçlü Yönler

  • Specialized expertise in fine tolerance injection molding.
  • Strong presence in the aerospace industry.
  • Global manufacturing footprint.
  • Long-standing customer relationships.

Zayıflıklar

  • Small market capitalization.
  • Low profit margin.
  • Dependence on cyclical industries.
  • Limited brand recognition.

Katalizörler

  • Ongoing: Increased demand for medical devices requiring high-precision plastic components.
  • Ongoing: Resurgence in the aerospace industry driving demand for specialist components.
  • Upcoming: Potential strategic acquisitions to expand product portfolio and geographic reach.
  • Ongoing: Investment in research and development to create new materials and technologies.
  • Ongoing: Geographic expansion in Asia to tap into high-growth markets.

Riskler

  • Potential: Economic downturns impacting demand in cyclical industries.
  • Ongoing: Increased competition from other manufacturers of plastic components.
  • Potential: Fluctuations in raw material prices affecting profit margins.
  • Potential: Technological obsolescence requiring continuous innovation.
  • Ongoing: Limited liquidity and higher volatility due to OTC market listing.

Büyüme Fırsatları

  • Expansion in the medical device market: The increasing demand for sophisticated medical devices presents a significant growth opportunity for Carclo's Technical Plastics division. As medical technology advances, the need for high-precision plastic components will continue to rise. Carclo can leverage its expertise in fine tolerance injection molding to capture a larger share of this market. The global medical device market is projected to reach $600 billion by 2028, providing a substantial runway for growth. Timeline: Ongoing.
  • Increased demand in the aerospace sector: The aerospace industry is experiencing a resurgence, driven by increased air travel and defense spending. Carclo's Aerospace division is well-positioned to benefit from this trend. The company's ability to provide specialist components for both commercial and military aircraft creates a stable and growing revenue stream. The global aerospace market is expected to grow at a rate of 4-5% annually over the next decade. Timeline: Ongoing.
  • Geographic expansion in Asia: The Asian market, particularly China and India, offers significant growth potential for Carclo. These regions are experiencing rapid economic growth and increasing demand for high-quality plastic components and aerospace parts. Carclo can expand its presence in Asia through strategic partnerships and investments in local manufacturing facilities. This expansion can diversify its revenue base and reduce its reliance on mature markets. Timeline: 2-3 years.
  • Development of new materials and technologies: Investing in research and development to create new materials and technologies can provide Carclo with a competitive edge. This includes exploring advanced polymers and molding techniques that can improve the performance and durability of its products. By staying at the forefront of technological innovation, Carclo can attract new customers and expand its market share. Timeline: Ongoing.
  • Strategic acquisitions: Carclo can pursue strategic acquisitions to expand its product portfolio and geographic reach. This includes acquiring companies with complementary technologies or access to new markets. Acquisitions can accelerate Carclo's growth and enhance its competitive position. Careful due diligence and integration are essential for successful acquisitions. Timeline: 3-5 years.

Fırsatlar

  • Expansion in the medical device market.
  • Growth in emerging markets.
  • Development of new materials and technologies.
  • Strategic acquisitions.

Tehditler

  • Economic downturns.
  • Increased competition.
  • Fluctuations in raw material prices.
  • Technological obsolescence.

Rekabet Avantajları

  • Specialized expertise in fine tolerance injection molding.
  • Long-standing relationships with key customers in the medical and aerospace industries.
  • Global presence with manufacturing facilities in multiple countries.
  • Proprietary technologies and processes for producing high-precision components.

CCEGF Hakkında

Carclo plc, founded in 1924 and based in Ossett, United Kingdom, specializes in the manufacture and sale of fine tolerance injection molded plastic parts. The company operates through three primary segments: Technical Plastics, Aerospace, and Central. The Technical Plastics division focuses on producing high-precision plastic components for the medical, optical, diagnostics, and electronics industries. These components are critical in devices requiring exacting specifications and reliability. The Aerospace division provides specialist components, including control cables, machined components, aerofoil blading, streamline wires, and tie rods, catering to both commercial and military aerospace applications. The Central segment supports the operational and strategic needs of the other two divisions. Carclo's global footprint extends across the United Kingdom, North America, the Czech Republic, China, and India, enabling it to serve a diverse international clientele. The company's products are essential in various applications, ranging from medical devices and diagnostic equipment to aircraft and electronic products. Carclo's commitment to precision and quality has established it as a key supplier in its niche markets. The company's long history and specialized expertise provide a competitive edge in the fine tolerance plastics and aerospace components industries.

Ne Yaparlar

  • Manufactures fine tolerance injection molded plastic parts.
  • Supplies components for the medical, optical, diagnostics, and electronics industries.
  • Provides specialist components for the commercial and military aerospace industries.
  • Offers control cables, machined components, aerofoil blading, streamline wires, and tie rods.
  • Operates in the United Kingdom, North America, the Czech Republic, China, and India.
  • Focuses on high-precision plastic components and aerospace parts.

İş Modeli

  • Manufacturing and selling fine tolerance injection molded plastic parts.
  • Providing specialist components to the aerospace industry.
  • Generating revenue through long-term contracts and project-based sales.
  • Operating through three segments: Technical Plastics, Aerospace, and Central.

Sektör Bağlamı

Carclo plc operates within the auto parts industry, a segment of the broader consumer cyclical sector. This industry is influenced by trends in automotive manufacturing, aerospace, and medical device production. The competitive landscape includes companies specializing in precision components and plastic molding. Carclo differentiates itself through its focus on fine tolerance injection molding and its presence in both the technical plastics and aerospace markets. The industry is subject to fluctuations in demand based on economic cycles and technological advancements. Carclo's ability to adapt to changing market conditions and maintain its technological edge is crucial for its long-term success.

Kilit Müşteriler

  • Medical device manufacturers.
  • Aerospace companies (both commercial and military).
  • Electronics manufacturers.
  • Optical and diagnostics equipment producers.
AI Güveni: 71% Güncellendi: 16 Mar 2026

Finansallar

Grafik & Bilgi

Carclo plc (CCEGF) hisse senedi fiyatı: Price data unavailable

Son Haberler

Analist Konsensüsü

Fikir Birliği Derecelendirmesi

CCEGF için Benzinga, Yahoo Finance ve Finnhub'dan toplanan Al/Tut/Sat önerileri.

Fiyat Hedefleri

CCEGF için Wall Street fiyat hedefi analizi.

MoonshotScore

46/100

Bu puan ne anlama geliyor?

MoonshotScore, CCEGF'ın büyüme potansiyelini inovasyon, pazar yıkımı, finansal sağlık ve momentum dahil olmak üzere birden fazla faktörde 0-100 ölçeğinde derecelendirir.

Yönetim: Franciscus Lodewijk Paulus Doorenbosch

CEO

Franciscus Lodewijk Paulus Doorenbosch serves as the CEO of Carclo plc. His professional background includes extensive experience in manufacturing and engineering. He has held various leadership positions in multinational corporations, focusing on operational efficiency, strategic planning, and business development. His expertise spans across multiple industries, including automotive, aerospace, and electronics. He is known for his ability to drive growth and improve profitability through innovation and strategic partnerships. His leadership style emphasizes collaboration and a customer-centric approach.

Sicil: Since assuming the role of CEO, Franciscus Lodewijk Paulus Doorenbosch has focused on streamlining operations and improving the company's financial performance. Key initiatives include implementing cost-saving measures, expanding the company's presence in emerging markets, and investing in research and development. Under his leadership, Carclo has secured several significant contracts in the aerospace sector and has launched new products in the medical device market.

CCEGF OTC Piyasa Bilgileri

The OTC Other tier represents the lowest tier of the OTC market, indicating that Carclo plc may not meet the minimum financial standards required for higher tiers like OTCQX or OTCQB. Companies in this tier often have limited reporting requirements and may not be subject to the same level of regulatory scrutiny as those listed on major exchanges like the NYSE or NASDAQ. This tier is often associated with higher risk due to the potential for less transparency and liquidity.

  • OTC Katmanı: OTC Other
  • Açıklama Durumu: Unknown
Likidite: Liquidity on the OTC Other market is typically very limited. Trading volume is often low, and bid-ask spreads can be wide, making it difficult to buy or sell shares quickly and at a favorable price. Investors may experience significant price slippage when executing trades. The limited liquidity can also increase price volatility.
OTC Risk Faktörleri:
  • Limited liquidity due to low trading volume.
  • Lack of regulatory oversight and transparency.
  • Potential for wider bid-ask spreads.
  • Higher price volatility.
  • Risk of delisting or suspension of trading.
Durum Tespiti Kontrol Listesi:
  • Verify the company's financial statements and disclosures.
  • Assess the company's management team and their track record.
  • Evaluate the company's business model and competitive landscape.
  • Review the company's legal and regulatory filings.
  • Understand the risks associated with investing in OTC stocks.
  • Consult with a financial advisor.
  • Check for any history of regulatory issues or fraud.
Meşruiyet Sinyalleri:
  • Long operating history (incorporated in 1924).
  • Global presence with operations in multiple countries.
  • Established customer base in the medical and aerospace industries.
  • Specialized expertise in fine tolerance injection molding.
  • Employment of over 1000 people.

CCEGF Hakkında Sıkça Sorulan Sorular

CCEGF için değerlendirilmesi gereken temel faktörler nelerdir?

Carclo plc (CCEGF) şu anda yapay zeka skoru 46/100, düşük puanı gösteriyor. Temel güçlü yan: Specialized expertise in fine tolerance injection molding.. İzlenmesi gereken birincil risk: Potential: Economic downturns impacting demand in cyclical industries.. Bu bir finansal tavsiye değildir.

CCEGF MoonshotScore'u nedir?

CCEGF şu anda MoonshotScore'da 46/100 (Derece D) alıyor, bu da düşük derecelendirme gösteriyor. Puan, 9 kantitatif KPI genelinde büyüme potansiyelini, finansal sağlığı, piyasa momentumunu ve risk faktörlerini değerlendirir. En son piyasa verileri kullanılarak günlük olarak yeniden hesaplanır. Bu puan yalnızca bilgilendirme amaçlıdır.

CCEGF verileri ne sıklıkla güncellenir?

CCEGF fiyatları ABD piyasa saatleri (hafta içi 9:30-16:00 ET) sırasında gerçek zamanlı olarak güncellenir. Temeller, üç aylık veya yıllık beyanlardan sonra yenilenir. Analist derecelendirmeleri ve yapay zeka öngörüleri günlük olarak güncellenir. Haberler, finans kaynaklarından sürekli olarak toplanır.

Analistler CCEGF hakkında ne diyor?

CCEGF için analist kapsamı, büyük araştırma şirketlerinden fikir birliği derecelendirmelerini (al, tut, sat), 12 aylık fiyat hedeflerini ve kazanç tahminlerini içerir. Temel veri noktaları: fikir birliği hedef fiyatı, kapsayan analist sayısı, son yükseltmeler veya düşürmeler ve kazanç beklentilerini aşma/aşamama geçmişi. Bu sayfadaki Analist Konsensüsü bölümüne bakın.

CCEGF'a yatırım yapmanın riskleri nelerdir?

CCEGF için risk kategorileri arasında piyasa riski, şirkete özgü risk (yönetim, rekabet), finansal risk (borç, nakit yakımı) ve makroekonomik risk (oranlar, enflasyon) yer alır. Yapay zeka analizi tarafından belirlenen önemli bir risk: Potential: Economic downturns impacting demand in cyclical industries.. 1,0'ın üzerindeki beta, S&P 500'den daha yüksek volatiliteyi gösterir. Ayrıntılar için bu sayfadaki Risk Faktörleri bölümünü inceleyin. Tüm yatırımlar kayıp riski taşır.

CCEGF'ın P/E oranı nedir?

CCEGF için P/E (fiyat-kazanç) oranı, mevcut hisse senedi fiyatını hisse başına kazancıyla karşılaştırır. Daha yüksek bir P/E büyüme beklentilerini gösterebilirken, daha düşük bir P/E değer veya azalan kazançlar gösterebilir. Anlamlı bir bağlam için CCEGF'ın P/E'sini sektördeki emsalleriyle ve S&P 500 ortalamasıyla karşılaştırın. Mevcut değerleme metrikleri için Finansallar sekmesini kontrol edin.

CCEGF aşırı değerli mi, yoksa düşük değerli mi?

Carclo plc (CCEGF)'ın aşırı değerli mi yoksa düşük değerli mi olduğunu belirlemek, birden fazla metriği incelemeyi gerektirir. Kapsamlı bir görünüm için değerleme oranlarını (P/E, P/S, EV/EBITDA) sektördeki emsallerle karşılaştırın. Bu bir finansal tavsiye değildir.

CCEGF'ın temettü verimi nedir?

Carclo plc (CCEGF) şu anda düzenli bir temettü ödemiyor veya temettü verimi verileri mevcut değil. Büyüme odaklı şirketler genellikle temettü ödemek yerine karları yeniden yatırır. En son temettü bilgileri ve ödeme geçmişi için Finansallar sekmesini kontrol edin.

Sorumluluk reddi: Bu içerik yalnızca bilgilendirme amaçlıdır ve yatırım tavsiyesi teşkil etmez. Her zaman kendi araştırmanızı yapın ve bir finans uzmanına danışın.

Resmi Kaynaklar

Analiz güncellendi AI Puanı günlük olarak yenilenir
Veri Kaynakları ve Metodoloji
Piyasa verileri Financial Modeling Prep ve Yahoo Finance tarafından sağlanmaktadır. AI analizi Stock Expert AI tescilli algoritmaları ile yapılmaktadır. Teknik göstergeler endüstri standardı hesaplamalarla üretilmektedir. Son güncelleme: .

Veriler yalnızca bilgilendirme amaçlı sağlanmıştır.

Analiz Notları
  • OTC market data may be less reliable than major exchange data.
  • Analyst coverage may be limited due to the company's size and listing.
Veri Kaynakları

Popüler Hisseler